−11.30 BKRW
176.54 MKRW
9.82 M
About ENSOL BIOSCIENCES
Sector
Industry
CEO
Hae-Jin Kim
Website
Headquarters
Daejeon
Employees (FY)
41
Founded
2001
ISIN
KR7140610007
FIGI
BBG00LWWQ044
Ensol Biosciences, Inc. manufactures and sells drugs. The firm develops BT·IT convergence technology (the core bioinformatics technology) such as in-silico genome analysis system, transcriptome analysis system, proteome analysis system and metabolome analysis system. It has been investing in developing bio-hydrogen energy, bio-environments, bio-foods and bio-cosmetics. The company was founded by Hae-Jin Kim on February 20, 2001 and is headquartered in Daejeon, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 140610 is 5180 KRW — it has decreased by 2.45% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ENSOL BIOSCIENCES stocks are traded under the ticker 140610.
140610 stock is 18.04% volatile and has beta coefficient of −0.36. Check out the list of the most volatile stocks — is ENSOL BIOSCIENCES there?
Yes, you can track ENSOL BIOSCIENCES financials in yearly and quarterly reports right on TradingView.
140610 stock has fallen by 10.69% compared to the previous week, the month change is a 50.14% rise, over the last year ENSOL BIOSCIENCES has showed a 61.46% decrease.
Today ENSOL BIOSCIENCES has the market capitalization of 57.50 B, it has increased by 42.06% over the last week.
No, 140610 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 140610 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENSOL BIOSCIENCES stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 41.00 employees. See our rating of the largest employees — is ENSOL BIOSCIENCES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENSOL BIOSCIENCES technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENSOL BIOSCIENCES stock shows the sell signal. See more of ENSOL BIOSCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.